SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-066767
Filing Date
2024-05-30
Accepted
2024-05-30 17:15:05
Documents
4
Period of Report
2024-05-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A sabs_def14a_fy24agm.htm DEF 14A 1317043
2 GRAPHIC img2457068_0.jpg GRAPHIC 12897
3 GRAPHIC img2457068_1.jpg GRAPHIC 640244
4 GRAPHIC img2457068_2.jpg GRAPHIC 274754
  Complete submission text file 0000950170-24-066767.txt   2595803
Mailing Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104
Business Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104 605-679-6980
SAB Biotherapeutics, Inc. (Filer) CIK: 0001833214 (see all company filings)

IRS No.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39871 | Film No.: 241006572
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)